DK10684A - Farmaceutisk praeparat til behandling af peptisk ulcus - Google Patents
Farmaceutisk praeparat til behandling af peptisk ulcus Download PDFInfo
- Publication number
- DK10684A DK10684A DK10684A DK10684A DK10684A DK 10684 A DK10684 A DK 10684A DK 10684 A DK10684 A DK 10684A DK 10684 A DK10684 A DK 10684A DK 10684 A DK10684 A DK 10684A
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- phenyl
- independently
- alkoxy
- hydroxyl
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 230000001175 peptic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 31
- -1 2,3-dihydroxypropyl Chemical group 0.000 abstract 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 125000003282 alkyl amino group Chemical group 0.000 abstract 5
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000004076 pyridyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- 239000001301 oxygen Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 abstract 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical group S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001786 isothiazolyl group Chemical group 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001715 oxadiazolyl group Chemical group 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 229950000964 pepstatin Drugs 0.000 abstract 1
- 108010091212 pepstatin Proteins 0.000 abstract 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 abstract 1
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000432026A CA1209919A (en) | 1982-07-12 | 1983-07-07 | Pharmaceutical methods and compositions |
| DK3186/83A DK318683D0 (da) | 1982-07-12 | 1983-07-11 | Fremgangsmade til fremstilling af anti-ulcusmidler |
| DK010684A DK165545C (da) | 1982-07-12 | 1984-01-10 | Farmaceutisk praeparat til behandling af peptisk ulcus paa enhedsdosisform |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39727182A | 1982-07-12 | 1982-07-12 | |
| US39727182 | 1982-07-12 | ||
| DK010684A DK165545C (da) | 1982-07-12 | 1984-01-10 | Farmaceutisk praeparat til behandling af peptisk ulcus paa enhedsdosisform |
| DK10684 | 1984-01-10 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK10684D0 DK10684D0 (da) | 1984-01-10 |
| DK10684A true DK10684A (da) | 1985-07-11 |
| DK165545B DK165545B (da) | 1992-12-14 |
| DK165545C DK165545C (da) | 1993-05-03 |
Family
ID=26063313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK3186/83A DK318683D0 (da) | 1982-07-12 | 1983-07-11 | Fremgangsmade til fremstilling af anti-ulcusmidler |
| DK010684A DK165545C (da) | 1982-07-12 | 1984-01-10 | Farmaceutisk praeparat til behandling af peptisk ulcus paa enhedsdosisform |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK3186/83A DK318683D0 (da) | 1982-07-12 | 1983-07-11 | Fremgangsmade til fremstilling af anti-ulcusmidler |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA1209919A (da) |
| DK (2) | DK318683D0 (da) |
-
1983
- 1983-07-07 CA CA000432026A patent/CA1209919A/en not_active Expired
- 1983-07-11 DK DK3186/83A patent/DK318683D0/da not_active Application Discontinuation
-
1984
- 1984-01-10 DK DK010684A patent/DK165545C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1209919A (en) | 1986-08-19 |
| DK10684D0 (da) | 1984-01-10 |
| DK165545B (da) | 1992-12-14 |
| DK318683D0 (da) | 1983-07-11 |
| DK165545C (da) | 1993-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69332735D1 (de) | Verwendung von Benzothiophene zur Behandlung von Hypercholesterolämie | |
| NL180206B (nl) | Verbinding en geneesmiddel met analgetische werking. | |
| DE69432243D1 (de) | 2-Phenyl-3-Aroylbenzothiophene zur Behandlung der menstruellen Symptome | |
| ES458689A1 (es) | Procedimiento de preparacion de nuevos derivados del ditiol-1,2. | |
| DE3852107D1 (de) | Bestimmte 3-substituierte 2-alkyl-benzofuran-derivate. | |
| DK10684A (da) | Farmaceutisk praeparat til behandling af peptisk ulcus | |
| ES446496A1 (es) | Procedimiento para la preparacion de nuevas 9-alcohila mi- noeritromicinas. | |
| ES8506634A1 (es) | Un procedimiento para la preparacion de derivados de isoquinuclidina. | |
| KR900701770A (ko) | 벤조 티아디아제핀 유도체 | |
| DE3579827D1 (de) | 3,4-disubstituierte-1,2,5-oxadiazole mit histamin h2-rezeptor-antagonisten-aktivitaet. | |
| ES470784A1 (es) | Procedimiento para la preparacion de aminoalcoxibenzofuranos | |
| ES468586A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas. | |
| SE8404729D0 (sv) | 2,5-disubstituted-4(3h)-pyrimidones having histamine h?712-receptor antagonist activity | |
| DK10784A (da) | Farmaceutisk praeparat til behandling af peptisk ulcus | |
| ES448696A1 (es) | Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas. | |
| EA199700200A1 (ru) | Способы ингибирования рака яичника | |
| ES8406457A1 (es) | Procedimiento de preparacion de derivados de piperacina | |
| FR2322592A1 (fr) | Nouveaux sulfonamides, leur preparation et leur application comme medicaments | |
| ES441229A1 (es) | Procedimiento para la obtencion de amidas de acido 2,3-dihi-dro-1-benzotiepin-4-carboxilico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |